Follow
Dr. V L Pushpa
Dr. V L Pushpa
Dept.of Chemistry,Sree Narayana College,Kollam,Kerala
Verified email at snckollam.ac.in
Title
Cited by
Cited by
Year
Theoretical insights into the anti-SARS-CoV-2 activity of chloroquine and its analogs and in silico screening of main protease inhibitors
AS Achutha, VL Pushpa, S Suchitra
Journal of proteome research 19 (11), 4706-4717, 2020
242020
Comparative molecular docking studies of phytochemicals as Jak2 inhibitors using Autodock and ArgusLab
AS Achutha, VL Pushpa, KB Manoj
Materials Today: Proceedings 41, 711-716, 2021
232021
Cyclin dependent kinase 4 inhibitory activity of Thieno [2, 3-d] pyrimidin-4-ylhydrazones–Multiple QSAR and docking studies
V Divya, VL Pushpa, KB Manoj
Journal of Molecular Structure 1183, 263-273, 2019
92019
Computational approach for generating robust models for discovering novel molecules as Cyclin Dependent Kinase 4 inhibitors
V Divya, VL Pushpa, S Sarithamol, KB Manoj
Journal of Molecular Graphics and Modelling 82, 48-58, 2018
72018
Comparative QSAR model generation using pyrazole derivatives for screening Janus kinase‐1 inhibitors
S Sarithamol, VL Pushpa, V Divya, KB Manoj
Chemical Biology & Drug Design 95 (5), 503-519, 2020
52020
Inter-annual and Long term Variability of Rainfall in Kerala
KBM V.K. Mini, V.L. Pushpa
Vayu Mandal 42 (1), 30-42, 2016
52016
An in silico approach to discover the best molecular modeling strategy for designing novel CDK 4 inhibitors
D Vasanthakumari, P Vadakkethil Lalithabhai, M Kanthimathi Bahuleyan
Chemical Biology & Drug Design 93 (4), 556-569, 2019
32019
Comparative study on janus kinase enzyme activity of pomegranate leaf extract and its active component ellagic acid for asthma.
VL PUSHPA, KB MANOJ
Oriental Journal of Chemistry 34 (2), 2018
32018
Genetic involvement of interleukin 4 for asthma and identification of potential phytochemical scaffold through molecular docking studies
S Sarithamol, V Divya, VR Sunitha, S Suchitra, VL Pushpa, KB Manoj
Int. J. Curr. Pharm. Res 10, 43-54, 2018
32018
QSAR Modeling, Docking and Insilico ADMET Studies of Lanosterol Synthase Inhibitors
DG Nair, VL Pushpa, KK Thomas
Oriental Journal of Chemistry 33 (4), 1837-1847, 2017
22017
High-throughput virtual screening followed by in vitro investigation to identify new lead inhibitors of Cyclin Dependent Kinase 4
V Divya, VL Pushpa
Journal of Molecular Graphics and Modelling 109, 108020, 2021
12021
2D and 3D QSAR model generation of CDK4 inhibitors
V Divya, VL Pushpa, S Sarithamol, KB Manoj
Bulletin of Pure & Applied Sciences-Chemistry 37 (1), 53-63, 2018
12018
In silico development for cholesterol management by the inhibition of lanosterol synthase
AS Soubhagya, UC Jaleel, VL Pushpa
IOSR-JAC 3, 33-37, 2012
12012
MACHINE LEARNING APPROACHES TO IDENTIFY POTENTIAL DNA Gyr B INHIBITORS FOR MYCOBACTERIUM TUBERCULOSIS
AAS SURENDRAN S, PUSHPA VL, MANOJ KB
International Journal of Biology, Pharmacy and Allied Sciences 10 (12), 4585 …, 2021
2021
Discovery of Prospective CDK4 inhibitor Molecule through virtual screening augumented by molecular docking and invitro studies
Divya.V, V.L. Pushpa
International Conference on Drug Discovery, 2020
2020
A Pharmacogenomic approach for the identification and validation of genetic markers behind CDK4 amplification leading to Cancer
V Divya, VL Pushpa, VR Sunitha, S Sarithamol, S Surendran, KB Manoj
2019
Discovery and validation of potential impact of cannabinoid receptor agonists by insilico means
S Sarithamol, V Divya, VL Pushpa, KB Manoj
Bulletin of Pure & Applied Sciences-Chemistry 37 (1), 88-98, 2018
2018
QSAR Studies of Lanosterol Synthase Inhibitors as Potential Antihyper Cholesterolemic Compounds
DG Nair, VL Pushpa, KK Thomas, KB Manoj
Oriental Journal of Chemistry 33 (6), 2949-2958, 2017
2017
QSAR Studies of Lanosterol Synthase Inhibitors as Potential Antihypercholesterolemic Compounds
VL Pushpa
2017
In Silico Development For Cholesterol Management-By The Inhibition Of Lanosterol Synthase
VL Pushpa
2012
The system can't perform the operation now. Try again later.
Articles 1–20